Advertisement
Advertisement
Business /

Money

The awarding of stablecoin issuer licences marks the city’s latest step towards embracing cryptocurrency’s most-traded cash substitute. Photo: Reuters
Fintech

HSBC, StanChart-led group among first to get stablecoin licences in Hong Kong

HSBC will launch its Hong Kong dollar stablecoin in the second half of this year, integrating it into its PayMe and mobile banking platforms.

videocam
Banking & finance

China healthcare stocks shine in Hong Kong amid Middle East turmoil

Banking & finance

OKX Ventures, HashKey Capital back Vietnam crypto platform’s pilot scheme bid

Electric & new energy vehicles

China amps up battery buildout to ‘10 times US 2025 capacity’

China’s battery expansion plans highlight a widening gap with the US, as renewable energy demand fuels rapid growth in storage systems.

An employee works on the production line at FoxESS, a global leader in the development of inverter and energy storage solutions. Photo: Getty Images
An employee works on the production line at FoxESS, a global leader in the development of inverter and energy storage solutions. Photo: Getty Images
Banking & finance

Mainland China and Hong Kong IPOs drive Citic to the top of banking fee rankings

Citic leads Asia-Pacific in fees in the first quarter as IPOs in Hong Kong and mainland China offset weaker debt and M&A activity.

Banking & finance

Yiwu market owner eyes Hong Kong IPO to support overseas expansion

Hong Kong listing plan comes after the company reported net profit of 4.2 billion yuan for 2025, up 36.8 per cent from a year earlier.

Advertisement
Advertisement
Advertisement
Banking & finance

Everest’s US$250 million buy signals rising global appetite for China biotech

Sovereign wealth funds from Singapore and Abu Dhabi join Chinese state capital as cross-border biotech licensing reaches record highs.

Cross-border out-licensing by Chinese drugmakers has reached a record US$60 billion in the first three months of the year. Photo: Shutterstock
Cross-border out-licensing by Chinese drugmakers has reached a record US$60 billion in the first three months of the year. Photo: Shutterstock
Banking & finance

More global firms eye Hong Kong for cheaper yuan loans, bonds: StanChart

The HKMA yuan facility charges an interest rate equal to the Shanghai interbank rate, which is 200 basis points lower than the US fed rate.

Electric & new energy vehicles

Chinese carmakers bet on solid-state batteries to drive next EV phase

Carmakers push next-generation battery tech as they chase longer range and improved safety, despite high costs.

Banking & finance

Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates

Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.

Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
Electric & new energy vehicles

More foreign marques face a do-or-die moment as Chinese buyers shun petrol cars

Following Skoda’s exit from China, other carmakers with falling sales are also likely to close shop this year, analysts say.

videocam
Skoda, Volkswagen’s mass-market brand, shut down its Chinese operations this year. Photo: AFP
Skoda, Volkswagen’s mass-market brand, shut down its Chinese operations this year. Photo: AFP
Electric & new energy vehicles

Tesla outraces China’s BYD in pure electric car sales to regain world’s top spot

Shrinking subsidies, new taxes sap China’s EV demand, giving Tesla an edge in global deliveries for first time since fourth quarter of 2024.

Electric & new energy vehicles

Leapmotor targets global growth with Europe R&D hub, eyes Canada assembly

Chinese EV maker lifts overseas sales target as rising fuel costs and easing tariffs boost demand abroad.

Electric & new energy vehicles

China EV makers surge back in March as subsidies and financing spur demand

Carmakers report strong month-on-month gains as policy support and new financing schemes lift buyer sentiment.

The EV rebound has been underpinned by renewed policy support at the local level. Photo: AFP
Banking & finance

Hong Kong’s anticipated stablecoin licence by end-March does not materialise

Analysts say the delay is most likely administrative and that the overall plan is still on track.

videocam
Hong Kong’s stablecoin initiative is part of efforts to become a global digital-asset hub. Photo: Getty Images
Hong Kong’s stablecoin initiative is part of efforts to become a global digital-asset hub. Photo: Getty Images
IPO

Hong Kong retains IPO crown but may lose to US mega listings over full year

Second place for IPO funds raised is Nasdaq, with US$5.65 billion from 18 listings, while the New York Stock Exchange ranks third.

Banking & finance

Hong Kong tycoon-backed start-up raises US$300 million to scale battery push

The California-based firm will use new funding to scale manufacturing and expand globally, with Hong Kong anchoring its regional push.

Advertisement
Advertisement
Advertisement
Banking & finance

Chinese company to use AI-powered testing to boost profits and fast-track IVF

China’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million from Hong Kong listing.

videocam
A Chinese biotech company is hoping AI technology will help to boost profits and speed up chromosome testing which is a vital part of In vitro fertilisation. Photo: Dreamstime/TNS
A Chinese biotech company is hoping AI technology will help to boost profits and speed up chromosome testing which is a vital part of In vitro fertilisation. Photo: Dreamstime/TNS
Banking & finance

Insilico Medicine signs AI drug development deal with Eli Lilly

Reaching development, regulatory and commercial milestones could see value of deal hit around US$2.75 billion.

Mainland China

Sketching a recovery: China puts next-gen art buyers in the frame amid slowdown

A US$83 trillion global wealth transfer in next two to three decades is beginning to reshape China’s art market: UBS.

Biomedicine: Companies

China biotech deals hit record as innovative drugs draw global interest

Deals reach US$60 billion in first quarter after analysts say Chinese biotech firms have shown substantial technological advancements.

The US$60 billion deal value represents a 73 per cent jump from the same period a year earlier. Photo: Shutterstock
China property

Rising second-hand home sales offer signs China’s property slump is bottoming out

Increased resale activity, driven by first-time buyers and policy support, is fuelling hopes that China’s property market may be stabilising.

In Shanghai, about 22,000 second-hand homes changed hands between March 1 and 23, up 170 per cent from the same period a month earlier. Photo: Getty Images
In Shanghai, about 22,000 second-hand homes changed hands between March 1 and 23, up 170 per cent from the same period a month earlier. Photo: Getty Images
Turkey

As tensions rise, Middle Eastern money and travellers pivot to Hong Kong

Wealthy Gulf visitors are extending their stays in Hong Kong as investors from the region look to hedge risk and tap Asian markets.

Mainland China

HKIC chief sees opportunities in advanced tech across China and Hong Kong

Hong Kong government-backed investor says strong returns and co-investment flows are reinforcing the region’s appeal to global capital.

Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.

videocam
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
Help preserve 120 years of quality journalism.
SUPPORT NOW